BioSpace News Archive

Policy

Opioid Lawsuits: Transparency, Possible Bankruptcy and Incendiary Language

With a major lawsuit in Oklahoma targeting Johnson & Johnson and Purdue Pharma’s involvement in the opioid epidemic starting in May, many of the legal documents are being released, with strategies and sometimes incendiary rhetoric coming to light.

March 13, 2019
·
5 min read
·
Mark Terry
Biotech Beach

Commissioner Lara holds public hearing to highlight most expensive drugs and rising health costs

Insurance Commissioner Ricardo Lara will hold a public hearing on rising prescription drug and health care costs—including the top 25 drugs for which Californians and their health insurers spent the most money.

March 13, 2019
·
1 min read
Job Trends

ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer

Protein forces a shift in cell type, a plasticity that promotes resistance to targeted therapy

March 13, 2019
·
5 min read
Business

BioForest Hotbed: The Fastest-Growing Life Science Market

A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.

March 13, 2019
·
5 min read
·
Mark Terry
Business

MC Services to support BIO-Europe Spring 2019 in Vienna as media partner

MC Services AG, the international public relations and investor relations firm, announced that it will support, as a media partner, BIO-Europe Spring® 2019, Europe’s largest springtime partnering conference for the global life sciences industry.

March 13, 2019
·
3 min read
Deals

Germany’s BioNTech Taps Banks to Prepare for $800 Million IPO

For BioNTech, the IPO will follow a funding round that brought about $270 million into the coffers of the privately-held company.

March 13, 2019
·
2 min read
·
Alex Keown
BioCapital

BioSpace’s Global Biopharma Roundup: March 14

In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.

March 13, 2019
·
4 min read
·
Alex Keown
Deals

Koligo Therapeutics to bring 3D bio-printing to the ASX

Koligo Therapeutics a regenerative medicine and 3D bio-printing company to list on the ASX under the stock ticker “KOL”.

March 13, 2019
·
5 min read
Business

Oxford Biomedica Teams With Microsoft to Use AI to Improve Gene Therapies

The goal is to improve the yield and quality of next-generation gene therapy vectors—typically viruses—using artificial intelligence (AI) and machine learning.

March 13, 2019
·
3 min read
·
Mark Terry
Drug Development

Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study

While the primary endpoint of disease-free survival was not met, Celgene said overall survival, which was a secondary endpoint, was improved by the combination treatment.

March 13, 2019
·
2 min read
·
Alex Keown